| __timestamp | BioMarin Pharmaceutical Inc. | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 621276000 | 75801000000 |
| Thursday, January 1, 2015 | 737887000 | 85403000000 |
| Friday, January 1, 2016 | 907234000 | 92281000000 |
| Sunday, January 1, 2017 | 1071860000 | 78356000000 |
| Monday, January 1, 2018 | 1175948000 | 76304000000 |
| Tuesday, January 1, 2019 | 1344582000 | 83430000000 |
| Wednesday, January 1, 2020 | 1336183000 | 94009000000 |
| Friday, January 1, 2021 | 1375760000 | 103077000000 |
| Saturday, January 1, 2022 | 1612370000 | 113840000000 |
| Sunday, January 1, 2023 | 1842161000 | 202972000000 |
| Monday, January 1, 2024 | 2273680000 | 163607000000 |
Unveiling the hidden dimensions of data
In the competitive world of pharmaceuticals, understanding who leads in profitability can offer valuable insights. Dr. Reddy's Laboratories Limited and BioMarin Pharmaceutical Inc. are two prominent players in this arena. Over the past decade, Dr. Reddy's has consistently outperformed BioMarin in terms of gross profit. In 2023, Dr. Reddy's gross profit was approximately 1100% higher than BioMarin's, showcasing its robust market presence.
From 2014 to 2023, Dr. Reddy's demonstrated a steady upward trend, peaking in 2023 with a gross profit of over 200 billion. In contrast, BioMarin's growth, while positive, was more modest, reaching its highest in 2023 with just under 2 billion. This stark difference highlights Dr. Reddy's strategic advantage and market dominance. However, data for 2024 is incomplete, leaving room for speculation on future trends.
Who Generates Higher Gross Profit? Eli Lilly and Company or Dr. Reddy's Laboratories Limited
Gross Profit Trends Compared: Johnson & Johnson vs BioMarin Pharmaceutical Inc.
Key Insights on Gross Profit: AbbVie Inc. vs Dr. Reddy's Laboratories Limited
AstraZeneca PLC and BioMarin Pharmaceutical Inc.: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Zoetis Inc. vs Dr. Reddy's Laboratories Limited
Gross Profit Analysis: Comparing GSK plc and BioMarin Pharmaceutical Inc.
Biogen Inc. vs BioMarin Pharmaceutical Inc.: A Gross Profit Performance Breakdown
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and BioMarin Pharmaceutical Inc.
R&D Insights: How Dr. Reddy's Laboratories Limited and BioMarin Pharmaceutical Inc. Allocate Funds
Key Insights on Gross Profit: Dr. Reddy's Laboratories Limited vs Travere Therapeutics, Inc.
Gross Profit Analysis: Comparing BioMarin Pharmaceutical Inc. and Vericel Corporation
BioMarin Pharmaceutical Inc. vs Ligand Pharmaceuticals Incorporated: A Gross Profit Performance Breakdown